Conversions from captopril to lisinopril at a dosage ratio of 5:1 result in comparable control of hypertension

Annals of Pharmacotherapy

Volumn 30, Issue 1, 1996, Pages 7-11

  Gill, Tajinder H ^a   Hauter, Fred ^a   Pelter, Mitchell A ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COUGHING; DOSE RESPONSE; DRUG COST; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0030050570     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000101     Document Type: Article

References (10)

1. Armayor GM, Lopez LM. Lisinopril: a new angiotensin-converting enzyme inhibitor. Drug Intell Clin Pharm 1988;22:365-72.
2. Dowd AL, Schwnacher AM, eds. Zestril. In: Physicians' desk reference. 49th ed Montvale, NJ: Medical Economics Data, 1995:2448-51.
3. Pullar T, Birtwell AJ, Wiles PG, Hay A, Freely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice or three times daily. Clin Pharmacol Ther 1988;44:540-5
4. Dowd AL, Schwnacher AM, eds. Capoten. In: Physicians' desk reference. 49th ed. Montvale, NJ: Medical Economics Data, 1995:710-4.
5. Olin BR, ed. Angiotensin converting enzyme inhibitors. In: Drug facts and comparisons. 48th ed St Louis: JB Lippincott, 1994:844-59.
6. American druggist blue book. 1988-1989, 1989-1990, 1990-1991, 1991-1992, 1992-1993, 1994 Annual Editions. New York: Hearst.
7. National High Blood Pressure Education Program. Treatment. In: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Bethesda, MD: National Institutes of Health, 1992:20.
8. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
9. Rumboldt Z, Simunic M, Bagatin J, Rumboldt M, Marinkovic M, Janezic A. Controlled multicenter comparison of captopril versus lisinopril in the treatment of mild-to-moderate arterial hypertension. Int J Clin Pharmacol Res 1993;13:35-41.
10. Bach R, Zardini P. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure. Am J Cardiol 1992;70:70C-7C.